Read the latest updates about the COVID-19 vaccine at Fox Chase →
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Assistant Professor
Kumar, S; Hall, L; Li, X; Downes, L; Shearer, A; Shelton, B; Gerring, S; McGarry, R. “Comparing Dosimetric Parameters and Clinical outcomes among different SBRT modalities.” IJROBP. Submitted.
Kumar, S; Feddock, J; Li, X; Shearer, A; Hall, L; Shelton, B; Arnold, S; McGarry, M. “An Update of a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.” IJROBP. Accepted- In Press. DOI: http://dx.doi.org/10.1016/j.ijrobp.2017.07.036
Kumar, S; Higgins, K; McGarry, R. “Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.” Frontiers of Oncology. Front. Oncol., 04 September 2017.
DOI: https://doi.org/10.3389/fonc.2017.00197
Verma, V; Shostrom, V; Kumar, S; Zhen, W; Hallemeier, C, Braunstein, S; Holland, J; Harkenrider, M; Ishkhanian, A; Neboori, H; Jabbour, S; Attia, A; Lee, P; Alite, F; Walker, J; Stahl, J; Wang, K; Bingham, B; Hadzitheodorou, C; Decker, R; McGarry, R; Simone, C. “Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeter) Non-Small Cell Lung Tumors.” Cancer. September 9, 2016. PubMed
Dong, L; Kudrimoti, M; Irwin, D; Chen, L; Kumar, S; Shang, Y; Huang, C; Johnson, E; Stevens, S; Shelton, B; Yu, G. "Diffuse optical measurements of head and neck tumor hemodynamics for early prediction of chemoradiation therapy outcomes," J. Biomed. Opt. 21(8), 085004 (2016), doi: 10.1117/1.JBO.21.8.085004.
Kumar, SS; Stockham, AL; Chao, ST; Ahluwalia, MS; Suh, JH. “Radiation necrosis: now you see it, now you don’t." Applied Radiology. February 2013.
Dr. Kumar on PubMed
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Assistant Professor
Kumar, S; Hall, L; Li, X; Downes, L; Shearer, A; Shelton, B; Gerring, S; McGarry, R. “Comparing Dosimetric Parameters and Clinical outcomes among different SBRT modalities.” IJROBP. Submitted.
Kumar, S; Feddock, J; Li, X; Shearer, A; Hall, L; Shelton, B; Arnold, S; McGarry, M. “An Update of a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.” IJROBP. Accepted- In Press. DOI: http://dx.doi.org/10.1016/j.ijrobp.2017.07.036
Kumar, S; Higgins, K; McGarry, R. “Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.” Frontiers of Oncology. Front. Oncol., 04 September 2017.
DOI: https://doi.org/10.3389/fonc.2017.00197
Verma, V; Shostrom, V; Kumar, S; Zhen, W; Hallemeier, C, Braunstein, S; Holland, J; Harkenrider, M; Ishkhanian, A; Neboori, H; Jabbour, S; Attia, A; Lee, P; Alite, F; Walker, J; Stahl, J; Wang, K; Bingham, B; Hadzitheodorou, C; Decker, R; McGarry, R; Simone, C. “Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeter) Non-Small Cell Lung Tumors.” Cancer. September 9, 2016. PubMed
Dong, L; Kudrimoti, M; Irwin, D; Chen, L; Kumar, S; Shang, Y; Huang, C; Johnson, E; Stevens, S; Shelton, B; Yu, G. "Diffuse optical measurements of head and neck tumor hemodynamics for early prediction of chemoradiation therapy outcomes," J. Biomed. Opt. 21(8), 085004 (2016), doi: 10.1117/1.JBO.21.8.085004.
Kumar, SS; Stockham, AL; Chao, ST; Ahluwalia, MS; Suh, JH. “Radiation necrosis: now you see it, now you don’t." Applied Radiology. February 2013.
Dr. Kumar on PubMed
15 PATIENT COMMENTS